about
MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic outputHIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domainsmiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in miceMicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell developmentInositol phosphatase SHIP1 is a primary target of miR-155Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorderMicroRNAs in B cell development and malignancymiRNA dysregulation in cancer: towards a mechanistic understandingLentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populationsHuntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survivalThe CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression.Cough-induced hemiplegic migraine with impaired consciousness in cystic fibrosis.Broad protection against influenza infection by vectored immunoprophylaxis in mice.MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.microRNA regulation of inflammatory responses.A case of pediatric B-Lymphoblastic leukemia presenting with a t(9;12)(p24;q11.2) involving JAK2 and concomitant MLL rearrangement with apparent insertion at 6q27Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene networkNF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies.MicroRNA function in myeloid biology.LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia.Antibody-based protection against HIV infection by vectored immunoprophylaxisMicroRNA-146a modulates B-cell oncogenesis by regulating Egr1.Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A.Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth.BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia.Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice.RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.Small lymphoid proliferations in extranodal locations.MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice.MicroRNAs: new regulators of immune cell development and function.Regulation of Marginal Zone B-Cell Differentiation by MicroRNA-146a.Physiological and pathological roles for microRNAs in the immune system.Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission.Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells.miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation.Computed tomography calcium quantification as a measure of atherosclerotic plaque morphology and stability.Long noncoding RNAs in hematopoietic malignancies.Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts.Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report.
P50
Q24293191-5495D6D8-DF51-4CD4-927F-6C0671672E64Q24305412-9EAD64B3-037B-41DD-8C45-82560BACAA0CQ24595073-3131F764-63FD-4CD0-8240-AF8E7931635DQ24620604-65FD1E6F-E379-4EFF-80AB-F1912517DAE9Q24648984-D36D72A8-FAB8-4A06-89D6-094E28E83065Q24649158-7BEC31E4-AD77-4967-98F4-6716335EDF54Q26862811-BBA8BF7C-FE1A-4831-8754-32535027E4A5Q27026420-A333A3AD-A673-45C9-8E23-6A50F773E304Q27322228-518F0C10-4457-41EC-8035-CBDEEED95BDCQ28217008-8C1CFBC3-2093-43DC-B7ED-288B14F765C7Q31137385-A071FCEB-5205-4BE2-933E-B265B06A0C30Q33153424-508482EF-E01A-4C03-B618-EAFC545949A8Q33649040-363C9DFA-E134-4E5B-87F6-95A17C9587A1Q34024981-5AEECEF7-2E17-449D-A8DB-5919EA1766AEQ34245279-2A27FC94-DACA-4054-A477-D0C4549A04ABQ34256192-69BA1685-0A06-4BDB-B6BE-A7FFED33CA5EQ34540749-3A2FF339-3950-4234-89EE-F611E9C05B03Q35022054-FF719CD9-4AEA-4461-8A12-05FC29E8D1E6Q35220370-84311EC2-0DD2-4567-B14D-5DE999336F84Q35611421-E5F2CA08-1F25-437F-9752-69EFC68637E0Q35658856-F20CD55E-6029-4509-8963-865A98B57736Q35793698-6C3D41BA-7CC5-4AA6-B0BE-BF39028BD879Q35837230-1FF32788-A7CB-4E7A-A73E-1DBFE91B6482Q35990849-4993199A-46C1-4484-B6A6-88AFE5B5FBE3Q36397963-DCAE2B28-A141-44EB-9D82-23C174CC055FQ36440069-C2DDC0D1-7C4D-4079-A012-B6A925AA35D4Q36737959-10CFFAC3-3CDD-41D2-8CCA-15501309F9F1Q36828059-D271579B-D5DF-4138-B0F4-F8309958D5B6Q36862518-66AA2889-0D4F-4C82-9675-DFD2A15590BEQ36864863-5661BCA0-7092-424C-8554-414F576E53EEQ37223449-1D475DBF-7CB6-416D-A817-6817D2204B0FQ37587236-F233E3F4-9F8B-455A-8D77-7C60D3B712BDQ37680666-4DE6FFF8-31DE-428F-869D-A57626B4F6B0Q37708741-E9C390F0-CA59-46DF-B6BB-C4791A5ED970Q40643300-5B6DE145-CB71-4F48-85C0-8FE253DC95F2Q42631760-7ECF1DF9-02F1-4DF1-9900-ABCEB04723EBQ46075454-AEC34970-83AB-41F7-B04E-E402B8EDDB63Q46191604-397F8445-9824-4B54-8705-166A7A65456FQ48005012-EB7B22B1-E0E3-40E4-82EE-DF8B5A64449FQ48518435-946670E7-E6F2-492D-9FE8-AF89E88608F4
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dinesh S Rao
@ast
Dinesh S Rao
@en
Dinesh S Rao
@es
Dinesh S Rao
@nl
Dinesh S Rao
@sl
type
label
Dinesh S Rao
@ast
Dinesh S Rao
@en
Dinesh S Rao
@es
Dinesh S Rao
@nl
Dinesh S Rao
@sl
prefLabel
Dinesh S Rao
@ast
Dinesh S Rao
@en
Dinesh S Rao
@es
Dinesh S Rao
@nl
Dinesh S Rao
@sl
P106
P21
P31
P496
0000-0002-0794-9337